Ironwood Pharmaceuticals Inc expected to post earnings of 25  cents a share - Earnings Preview

Ironwood Pharmaceuticals

04/08/2023 18:26

* Ironwood Pharmaceuticals Inc  IRWD.OQ   IRWD.O  is
expected
to show a rise in quarterly revenue when it reports  results on
August 8. 
    * The Boston Massachusetts-based  company is expected to
report  a
6.7% increase in revenue to $103.715 million from $97.23 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Ironwood
Pharmaceuticals
Inc is for earnings of 25 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is $15​, above​ its last closing price
of $11.01. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  0.23        0.24       0.25      Beat    3.1
 Dec. 31 2023  0.26        0.27       0.27      Met     0
 Sep. 30 2022  0.26        0.27       0.28      Beat    5.7​
 Jun. 30 2022  0.30        0.30       0.21      Missed  -28.8
 ​​Mar.        0.25        0.26       0.21      Missed  -17.6
 31 2022                                                
 Dec. 31 2021  0.36        0.35       0.27      Missed  -23.6​
 Sep. 30 2021  0.31        0.31       0.33      Beat    6.5
 Jun. 30 2021  0.23        0.23       0.34      Beat    47.8
 This summary was machine generated August 4 at 17:26 GMT.  All
figures in US dollars  unless otherwise stated